Post‐marketing research and its outcome for novel anticancer agents approved by both the FDA and EMA between 2005 and 2010: A cross‐sectional study
Jean‐David Zeitoun; Gabriel Baron; Alexandre Vivot; Ignacio Atal; Nicholas S Downing; Joseph S Ross; Philippe Ravaud
Author Information: Centre d'Épidémiologie Clinique, Hôpital Hôtel Dieu, Assistance Publique‐Hôpitaux de Paris
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.